Table 5.

Hsa-142-3p targeted proliferation genes (shown in Figure 5C) with a significant differential expression (p < 0.05; two-sample t-tests) in sensitive versus resistant CCLE NSCLC cell lines to specific drugs. Drug activity measurements include IC₅₀, EC₅₀, ln(IC₅₀), and ln(EC₅₀). Red font indicates that the gene has a higher expression in the resistant cell lines than in the sensitive cell lines. Blue font indicates the gene has a lower expression in the resistant cell lines than in the sensitive cell lines.

Drugs	PRISM	GDSC1	GDSC2
Cisplatin	SNRNP200	SF3B1 , RAN	CSE1L
Erlotinib	SNRNP200	CSE1L
Gefitinib		COPA
Paclitaxel			NUP205
Pemetrexed		RAN , SNRPD1